Cravatex Ltd
NSE: BSE: 509472
₹344
-3 (0.86%)
Sun, 22 Nov 2026, 03:12 pm
Market Cap (in Cr)90.46
PE Ratio11.10
Dividend7.43
Cravatex Analysis
dividend
Pros
- Dividends per share have increased over the past 10 years.
Cons
- Dividends paid are not well covered by earnings (0.1x coverage).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Cravatex's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Cravatex's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
Pros
- Cravatex is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Cravatex is profitable, therefore cash runway is not a concern.
- Cravatex is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 2.1x debt.
- Cravatex's cash and other short term assets cover its long term commitments.
Cons
- Debt is not well covered by operating cash flow (14.8%, less than 20% of total debt).
- The level of debt compared to net worth has increased over the past 5 years (153.2% vs 561.9% today).
- Interest payments on debt are not well covered by earnings (EBIT is 1.9x annual interest expense, ideally 3x coverage).
- Cravatex's level of debt (561.9%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
Pros
- The tenure for the Cravatex board of directors is about average.
- Rajesh's remuneration is lower than average for companies of similar size in India.
- Rajesh's compensation has been consistent with company performance over the past year, both up more than 20%.
Cons
misc
Pros
Cons
- Cravatex is not covered by any analysts.
past
Pros
- Cravatex has delivered over 20% year on year earnings growth in the past 5 years.
- Cravatex has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
Cons
- Cravatex's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Cravatex used its assets less efficiently than the IN Retail Distributors industry average last year based on Return on Assets.
- Cravatex has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Cravatex's 1-year earnings growth is negative, it can't be compared to the IN Retail Distributors industry average.
value
Pros
- 509472 outperformed the Retail Distributors industry which returned -12% over the past year.
- 509472 outperformed the Market in India which returned -14.5% over the past year.
- BSE:509472 is up 20.4% outperforming the Retail Distributors industry which returned 7.5% over the past month.
- BSE:509472 is up 20.4% outperforming the market in India which returned 8% over the past month.
Cons
- Cravatex's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Cravatex's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Cravatex is overvalued based on assets compared to the IN Retail Distributors industry average.
- Cravatex is overvalued based on earnings compared to the IN Retail Distributors industry average.
- Cravatex is overvalued based on earnings compared to the India market.